TransMedics to Participate in the Canaccord Genuity Virtual MedTech, Diagnostics, and Digital Health & Services Forum

Rhea-AI Summary

TransMedics Group, Inc. (Nasdaq: TMDX), a leader in organ transplantation technology, will host one-on-one meetings at the Canaccord Genuity MedTech, Diagnostics, and Digital Health & Service Forum on November 18, 2021. The company is dedicated to improving organ transplant therapy for patients with end-stage lung, heart, and liver failure. TransMedics specializes in portable extracorporeal warm perfusion and assessment of donor organs, aiming to enhance organ quality and increase the utilization of donor organs.

ANDOVER, Mass., Nov. 4, 2021 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that members of the management team will host one-on-one meetings at the upcoming Canaccord Genuity MedTech, Diagnostics, and Digital Health & Service Forum on Thursday, November 18, 2021.

For more information on the company, please visit https://investors.transmedics.com/. 

About TransMedics Group, Inc.
TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure.

Investor Contact:
Brian Johnston
631-807-1986
Investors@transmedics.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/transmedics-to-participate-in-the-canaccord-genuity-virtual-medtech-diagnostics-and-digital-health--services-forum-301415984.html

SOURCE TransMedics Group, Inc.

FAQ

What is TransMedics Group's participation in the Canaccord Genuity Forum?

TransMedics Group will host one-on-one meetings at the Canaccord Genuity MedTech, Diagnostics, and Digital Health & Service Forum on November 18, 2021.

What technologies does TransMedics Group specialize in?

TransMedics specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation.

What is the main focus of TransMedics Group?

TransMedics focuses on transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure.

When was the press release issued for TransMedics Group?

The press release was issued on November 4, 2021.

How can I find more information about TransMedics Group?

More information about TransMedics Group can be found on their investor website at https://investors.transmedics.com/.